share_log

上海医药(601607.SH):沙库巴曲缬沙坦钠片获得批准生产

Shanghai Pharmaceutical (601607.SH): Sacubatl Valsartan sodium tablets approved for production

Gelonghui Finance ·  May 14 05:03

On May 14, Ge Longhui Pharmaceutical (601607.SH) announced that the company's holding subsidiary Changzhou Pharmaceutical Factory Co., Ltd. (hereinafter referred to as “Changzhou Pharmaceutical Factory”) has received the “Drug Registration Certificate” (certificate numbers: 2024S00767, 2024S00768) issued by the State Drug Administration, and the drug has been approved for production. Sacubatl valsartan sodium tablets are mainly used to treat symptoms such as chronic heart failure and primary hypertension.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment